EULAR & OARSI 2022 Presentations

AKLRD’s data on APPA’s Phase IIa Human Clinical Trial, ‘The Efficacy & Safety of APPA in Symptomatic Knee Osteoarthritis’, was presented as a scientific abstract and as a poster at the congress for European Alliance of Associations for Rheumatology (EULAR) 2022.

The data was also presented as a poster at the 2022 OARSI World Congress On Osteoarthritis (Osteoarthritis Research Society International). OARSI is a key congress focused exclusively on osteoarthritis and ALKRD was proud to sponsor of this year’s ‘Rising Star Awards’ at the congress.

Please click here for OARSI Poster and the EULAR Abstract.